Pro Share Advisors LLC Compugen LTD Transaction History

Pro Share Advisors LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$2.76 - $4.64 $32,625 - $54,849	-11,821 Closed	0 $0
Q4 2021 Feb 08, 2022	SELL	$4.09 - $7.16 $24,998 - $43,761	-6,112 Reduced 34.08%	11,821 $51,000
Q3 2021 Nov 12, 2021	BUY	$5.8 - $8.02 $16,808 - $23,241	2,898 Added 19.28%	17,933 $107,000
Q2 2021 Aug 13, 2021	BUY	$6.87 - $9.16 $23,763 - $31,684	3,459 Added 29.88%	15,035 $124,000
Q1 2021 May 14, 2021	SELL	$7.67 - $13.77 $9,288 - $16,675	-1,211 Reduced 9.47%	11,576 $99,000
Q4 2020 Feb 09, 2021	SELL	$12.07 - $17.95 $6,819 - $10,141	-565 Reduced 4.23%	12,787 $155,000
Q3 2020 Nov 13, 2020	BUY	$14.16 - $19.45 $16,538 - $22,717	1,168 Added 9.59%	13,352 $217,000
Q2 2020 Aug 03, 2020	BUY	$6.97 - $17.12 $84,922 - $208,590	12,184 New	12,184 $183,000
Q1 2020 May 15, 2020	SELL	$5.79 - $11.83 $78,118 - $159,610	-13,492 Closed	0 $0
Q4 2019 Feb 12, 2020	BUY	$3.9 - $6.16 $52,618 - $83,110	13,492 New	13,492 $80,000
Q4 2017 Feb 14, 2018	SELL	$2.35 - $4.0 $67,680 - $115,200	-28,800 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$2.75 - $3.95 $7,023 - $10,088	2,554 Added 9.73%	28,800 $109,000
Q2 2017 Aug 11, 2017	BUY	N/A	26,246	26,246 $100,000

13.3M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Pro Share Advisors LLC with notifications on news.